Posted by AGORACOM-JC
at 9:33 AM on Wednesday, January 6th, 2021
Announced the awarding of a new patent for a vertical take-off and landing (VTOL) cargo delivery drone with variable center of gravity.
The design is ideal for Beyond Visual Line of Sight (BVLOS) and for transporting goods in hard to reach areas or flight over people at night.
Los Angeles, CA, Jan. 06, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, is pleased to announce the awarding of a new patent for a vertical take-off and landing (VTOL) cargo delivery drone with variable center of gravity.
The design is ideal for Beyond Visual Line of Sight (BVLOS) and for transporting goods in hard to reach areas or flight over people at night.
US Patent No. 10,807,707 is an unmanned aircraft system (UAS) configured for both vertical take-off and landing (VTOL) and fixed-wing flight operations includes forward, and aft wing assemblies mounted to the fuselage, each wing assembly including port and starboard nacelles terminating in motor-driven rotors powered by an onboard control system capable of adjusting rotor speeds.
Posted by AGORACOM-JC
at 8:29 AM on Wednesday, January 6th, 2021
Avicanna Advances Pharmaceutical Epilepsy Program With Collaboration With the University Health Network and GMP Manufacturing of its First Pharmaceutical Preparation
The multi-level cannabinoid-based collaboration with leading epilepsy researcher Dr. Peter Carlen at the world-renowned Krembil Research Institute at UHN is also supported by a Mitacs Accelerate program grant.
UHN scientists will be analyzing Avicanna’s RHO Phyto™ cannabinoid-based products for their efficacy on comorbidities and seizure control in addition to identifying optimized cannabinoid and non-cannabinoid ratios for future drug development.
First fully GMP and ICH compliant manufacturing of Avicanna’s proprietary pharmaceutical preparation to treat epilepsy has been completed by Altea Farmaceutica S.A. in preparation for registration and commercialization in South America.
TORONTO, Jan. 06, 2021 — Avicanna Inc. (“ Avicanna ” or the “ Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that the Company has entered into a master services agreement (the “ Master Services Agreement ” ) with the University Health Network (“ UHN ”) for projects to be performed by Dr. Peter Carlen as the principal investigator related to epilepsy. Additionally, the company has completed the technical transfer and first pharmaceutical pilot production of its epilepsy drug candidate at Altea Farmaceutica S.A. (“ Altea ”) in Bogota, Colombia, a major step required for the final preparation for its registration and commercialization in South America.
Posted by AGORACOM-JC
at 8:19 AM on Wednesday, January 6th, 2021
Entered into development and supply agreements with a technology leader in photonic neural network systems for Artificial Intelligence (AI) applications.
Artificial Intelligence, at the cusp of its own revolutionary impact to humanity, is driving an unprecedented demand for computation at the same time that the physics of digital semiconductors, driven by Moore’s law, is reaching its end.
Chipset market for AI applications is projected to grow from approximately $18 billion in 2020 to over $65 billion by 2025.
TORONTO, Jan. 06, 2021 — POET Technologies Inc. (“ POET ” or the “ Company ”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, today announced that it has entered into development and supply agreements with a technology leader in photonic neural network systems for Artificial Intelligence (AI) applications.
Artificial Intelligence, at the cusp of its own revolutionary impact to humanity, is driving an unprecedented demand for computation at the same time that the physics of digital semiconductors, driven by Moore’s law, is reaching its end. Transistor scaling is approaching its limits and AI accelerator companies are struggling to keep pace with demands, particularly in “edge” applications that require greater power and cost efficiency. Domain-specific architectures targeted to AI workloads can make up for some of the slowdown in transistor advances but that approach also has its limits.
Posted by AGORACOM-JC
at 8:12 AM on Wednesday, January 6th, 2021
KABN North America launches the KABN prepaid Visa Card to support its Liquid Avatar users and provides online banking solutions with XTM Inc.
Announces today that together with fintech innovator, XTM Inc. (CSE:PAID), it will launch its KABN prepaid Visa Card and digital banking platform to support its partnered challenger bank initiatives in North America.
Partner managed platform will initially include a multi-currency and KABN KASH integrated account platform, connected to the KABN Visa Card, which has the capability to add additional 3rd party currency, investment, and other financial services solutions.
TORONTO, ON / January 6, 2021 / KABN Systems NA Holdings Corp.(CSE:KABN)(OTC PINK:TRWRF)(FRA:4T51) (the “Company“, “KABN North America” or “KABN NA“) (www.kabnsystemsna.com), a North American Fintech solutions company specializing in empowering individuals to manage, control and generate value from their biometrically-verified Self Sovereign Identity (“SSI”) through its Liquid Avatar (www.liquidavatar.com) platform, announces today that together with fintech innovator, XTM Inc. (CSE:PAID), it will launch its KABN prepaid Visa Card and digital banking platform to support its partnered challenger bank initiatives in North America.
The partner managed platform will initially include a multi-currency and KABN KASH integrated account platform, connected to the KABN Visa Card, which has the capability to add additional 3rd party currency, investment, and other financial services solutions. These services will be available through the Liquid Avatar app, which provides users with a biometrically, verified, SSI solution allowing them to manage a wide range of verifiable credentials, online site and program access, and data permissions, putting control over personal data where it belongs – in the hands of its owners.
Posted by AGORACOM-JC
at 8:02 AM on Wednesday, January 6th, 2021
Announced that Mr. Philip (Zhengquan) Chen has been appointed to its Board of Directors.
Mr. Chen is an experienced finance professional and has participated in numerous capital markets transactions in both Canada and the USA. He is also the Managing Partner of Dynaco Capital Inc.
TORONTO, ON / January 6, 2021 / Kontrol Energy Corp.(CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“), a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce that Mr. Philip (Zhengquan) Chen has been appointed to its Board of Directors.
Mr. Chen is an experienced finance professional and has participated in numerous capital markets transactions in both Canada and the USA. He is also the Managing Partner of Dynaco Capital Inc.
“We are very pleased to have Mr. Chen join our Board, as an independent board member, as we continue to work in preparation of an uplisting to senior North American stock exchanges,” says Paul Ghezzi, CEO Kontrol.
Posted by AGORACOM-JC
at 7:55 AM on Wednesday, January 6th, 2021
Announced the Company has launched as of January 4, 2021, a Concierge Covid-19 testing service for the travelling public in both Toronto and Vancouver.
Concierge service is designed for individuals looking to be tested from the comfort of their own homes rather than using government locations and having to line up with crowds waiting to be tested at such locations.
Toronto, Ontario–(January 6, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce the Company has launched as of January 4, 2021, a Concierge Covid-19 testing service for the travelling public in both Toronto and Vancouver.
The Company, through its wholly owned subsidiary, Innocan Pharma Ltd., has signed certain agreements with world leading companies for the fulfillment, logistics, and service of the website
The new website has been designed to offer a user-friendly experience with excellent navigation and functionality, allowing consumers to see the full product information to enhance the shopping experience
Herzliya, Israel and Calgary, Alberta–(January 5, 2021) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the “Company” or “Innocan“), is pleased to announce the launch of its commercial web-platform, shop.innocanpharma.com. The Company, through its wholly owned subsidiary, Innocan Pharma Ltd. (“Innocan Israel”), has signed certain agreements with world leading companies for the fulfillment, logistics, and service of the website. The new website has been designed to offer a user-friendly experience with excellent navigation and functionality, allowing consumers to see the full product information to enhance the shopping experience.
The online product distribution will be led and handled by Brandzon Co Ltd. (www.brandzon.co), a company which specializes in ecommerce growth and worldwide acceleration. The Brandzon team has a proven sales track record worldwide, with global 3PL (Third-Party-Logistics) capabilities.
Roni Kamhi, CEO & Co-founder of Brandzon said, “We believe that Innocan is a leading innovative pharmaceutical company that has the potential to bring an advanced formulated product into the skincare market with the science to back it. Together we can achieve success in the ecommerce space and generate revenue for both companies.”
“We are pleased to unveil our new website shop.innocanpharma.com,” says Iris Bincovich, founder and CEO of Innocan Pharma. “The site will allow consumers to browse smoothly through our product collection and find the perfect product that will meet their requirements. This is a major milestone and a great opportunity for Innocan to start with B2C operation that will secure a new and sustainable source of income for the Company.”
About Innocan
The Company, through Innocan Israel, is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD“). Innocan Israel and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the COVID-19 coronavirus using CBD. CBD-loaded exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.
Innocan Israel signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem to develop a CBD drug delivery platform based on a unique-controlled release liposome to be administrated by injection. Innocan Israel plans, together with Professor Berenholtz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University, to test the liposome platform on several potential indications. Innocan Israel is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.
For further information, please contact:
For Innocan Pharma Corporation: Iris Bincovich, CEO +972-54-3012842 [email protected]
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Caution regarding forward-looking information
Certain information set forth in this news release, including, without limitation, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements.
Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.
Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.
Posted by AGORACOM-JC
at 11:49 AM on Tuesday, January 5th, 2021
As a PlantX partner, Else will expand product distribution, drive global awareness and sales via all Plant X channels, digital and physical locations.
Announced that it is will be listed on Plant X, the digital face of the Plant-Based community and one-stop-shop for plant-based products, as the first product available for order in the newly created baby products section of Plant X’s ecommerce platform ( www.PlantX.ca/baby ).
Plant X is now a publicly traded company in the U.S., Canada and Germany with brick and mortar locations on the way in North America and Tel Aviv, Israel .
VANCOUVER, BC , Jan. 5, 2021 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company , is pleased to announce that it is will be listed on Plant X, the digital face of the Plant-Based community and one-stop-shop for plant-based products, as the first product available for order in the newly created baby products section of Plant X’s ecommerce platform ( www.PlantX.ca/baby ).
“We’re thrilled to be listed on the Plant X platform, and there’s a real need for such a community. Joining this innovative online platform solely dedicated to Plant-Based companies, aligns perfectly with our mission to bring real clean label, whole, sustainable, Plant-Based options for parents to nourish their children,” said Hamutal Yitzhak , CEO and Co-Founder of Else Nutrition. “We’re proud to be part of platform of like-minded, purpose-driven brands and raising awareness for Plant-Based Nutrition and its benefits to a growing segment of consumers. This will help bolster our presence in both North America and Europe ,” she added.
“Launching the new baby products section of PlantX.com with Else Nutrition is very exciting for us,” said Julia Frank , Plant X CEO. “We’ve seen the success of the baby formula vertical and having it in our Plant-Based umbrella only adds to the potential in this space.”
Plant X is now a publicly traded company in the U.S., Canada and Germany with brick and mortar locations on the way in North America and Tel Aviv, Israel .
About PlantX Life Inc.
As the digital face of the Plant-Based community, Plant X’s platform is the one-stop-shop for everything Plant-Based. With its fast-growing category verticals, the Company offers customers across North America more than 10,000 Plant-Based products. In addition to offering meal and indoor plant deliveries, the Company currently has plans underway to expand its product lines to include cosmetics, clothing, and its own water brand — but the business is not limited to an e-commerce platform. The Company uses its digital platform to build a community of like-minded consumers, and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs, and brands. The Company eliminates the barriers to entry for anyone interested in living a Plant-Based lifestyle, and thriving in a longer, healthier, and happier life.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . Else Plant-Based Toddler Nutrition was a 2020 Top-seller on Amazon, in the New Product within Baby & Toddler Formula Category. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA, Children’s Hospital of Colorado, Tel Aviv University, Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Posted by AGORACOM-JC
at 11:27 AM on Tuesday, January 5th, 2021
Announced the Calrissian Cup, a $15,000 prize pool Star Wars Squadrons esports event, in partnership with Aces 5 and Crimson Wings.
The $15,000 prize pool is the largest ever offered for a Star Wars Squadron series.
Series will feature monthly events broadcast live on Twitch with the grand finale in October 2021.
By holding the Calrissian Cup, the first major Star Wars Squadron esports series, TGS lays the foundation for the game and also becomes the standard esports platform for anyone looking to compete.
VANCOUVER, BC , Jan. 5, 2021 – TGS Esports Inc. (” TGS ” or the ” Company “) (TSXV: TGS ) (FRA: 5RH) is pleased to announce the Calrissian Cup, a $15,000 prize pool Star Wars Squadrons esports event, in partnership with Aces 5 and Crimson Wings. The $15,000 prize pool is the largest ever offered for a Star Wars Squadron series.
The series will feature monthly events broadcast live on Twitch with the grand finale in October 2021. By holding the Calrissian Cup, the first major Star Wars Squadron esports series, TGS lays the foundation for the game and also becomes the standard esports platform for anyone looking to compete.
The events will be held on the following dates:
Jan 16th & 17th – Community Tournament feat. $400 Prize Pool
Feb 27th & 28th – Winter Open Tournament feat. $2000 Prize Pool
March 20th & 21st – Community Tournament feat. $400 Prize Pool
April 17th & 18th – Spring Open Tournament feat. $2000 Prize Pool
May 15th & 16th – Community Tournament feat. $400 Prize Pool
June 12th & 13th – Community Tournament feat. $400 Prize Pool
July 17th & 18th – Summer Open Tournament feat. $2000 Prize Pool
August 14th & 15th – Community Tournament feat. $400 Prize Pool
Sept 18th & 19th – Fall Open Tournament feat. $2000 Prize Pool
October 2nd & 3rd – Championship feat. $5000 Prize Pool
The winners of the Winter, Spring, Summer, and Fall Open Tournaments will automatically qualify for the Championship. The remaining eight spots in the Championship will be made up of the teams that accumulate the most points during the entire series. Points are up for grabs at each monthly event. Registration is open now and can be found at www.thegamingstadium.com . All events will be broadcast live on Twitch.
“The recent updates to Squadrons allowing for custom matchmaking and spectating have made it easier than ever to put on events. There is no true competitive scene for this title which is why we see this as such a massive opportunity to make the Calrissian Cup the global standard for Star Wars Squadrons esports.” said Spiro Khouri , CEO of TGS. “Star Wars is such a big part of many peoples lives, including mine, and to now bring a competitive esports element to this community is something we are very excited for.”
“When we set out to build the Calrissian Cup we had big goals. We partnered with all of the Squadrons communities and laid a great foundation.” said Ezra Kille , Management, Aces 5. “Having now connected with TGS we can bring this event to life in a bigger way than we ever imagined. The prize pool we are offering is amazing and we cannot wait to get our first event off the ground!”
TGS Esports Inc. is an esports organization focused on providing an unparalleled esports experience through its expertise in online and in-person event management, broadcast production, and Pepper Esports’ tournament software. TGS is the owner of Canada’s first dedicated esports arena, The Gaming Stadium, located in Richmond, British Columbia , which opened in June 2019 . The Gaming Stadium hosts regular online tournaments as well as provides high quality broadcast production for any event. For more information, visit www.thegamingstadium.com .
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
On behalf of the Board of Directors
” Spiro Khouri “ Spiro Khouri , CEO TGS Esports Inc.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. The risks include the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic and other risks that are customary to transactions of this nature. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them.
This press release is not an offer of the securities for sale in the United States . The securities have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an exemption from registration. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful.
Posted by AGORACOM-JC
at 11:11 AM on Tuesday, January 5th, 2021
Announced two investments, for a total of $530,000 in Electric Metals (USA) Ltd. a multi-commodity US-based resource company focused on their 100% owned Corcoran Canyon Silver Project in Nevada and Emily Manganese Project in Minnesota.
In the first private placement, The Company has acquired 1,000,000 shares (the “Shares”) at a price of $0.20 per Share in EML.
In the second private placement, The Company has acquired 1,000,000 Subscription Receipts at a price of $0.33 per Sub Receipts. Each Sub Receipts will entitle ThreeD to receive one (1) common share of EML (a “Common Share”) and one-half (1/2) of one Common Share purchase warrant (each whole warrant, a “Warrant”), with each whole warrant exercisable at $0.60 per Warrant.
The Warrants will expire two (2) years from the date of issuance.
Sheldon Inwentash has also agreed to come on as Chairman of the Board of Directors to NBS, which will take effect upon the closing of the proposed transaction with NBS.
TORONTO, Jan. 05, 2021 — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce two investments, for a total of $530,000 in Electric Metals (USA) Ltd. (“EML ”), a multi-commodity US-based resource company focused on their 100% owned Corcoran Canyon Silver Project in Nevada and Emily Manganese Project in Minnesota.
In the first private placement, The Company has acquired 1,000,000 shares (the “Shares”) at a price of $0.20 per Share in EML.
In the second private placement, The Company has acquired 1,000,000 Subscription Receipts (the “Sub Receipts”) at a price of $0.33 per Sub Receipts. Each Sub Receipts will entitle ThreeD to receive one (1) common share of EML (a “Common Share”) and one-half (1/2) of one Common Share purchase warrant (each whole warrant, a “Warrant”), with each whole warrant exercisable at $0.60 per Warrant. The Warrants will expire two (2) years from the date of issuance.
EML signed a definitive scheme implementation agreement, effective 31st December 2020, with NBS Capital Inc. (“NBS”) (TSXV: NBS.P), as announced yesterday by NBS. Pursuant to this Agreement, NBS will acquire all of the shares of EML via share exchange for an equivalent number of NBS shares, which will result in EML becoming a wholly owned subsidiary of NBS. NBS will change its name change to Nevada Silver Corporation on closing of the proposed transaction, reflecting the focus of EML on its principal Nevada silver asset.
Sheldon Inwentash has also agreed to come on as Chairman of the Board of Directors to NBS, which will take effect upon the closing of the proposed transaction with NBS.
Sheldon Inwentash, Chairman and CEO of ThreeD Capital stated “ThreeD Capital prides itself on discovering great companies before they become known to the general investment community, and EML is no exception. With 100% ownership of a US-based primary silver-gold asset with existing resources and significant upside potential, I am confident EML will deliver exceptional value to IDK shareholders.”
Gary Lewis, Director and CEO of EML commented, “We are delighted to welcome ThreeD Capital onto the EML register and Mr. Sheldon Inwentash as our incoming Chairman at such a pivotal time in the company’s development. EML has built a strong asset base and technical capability which, when coupled with the reputation, rolodex and investment nous of Mr. Inwentash, will make for a very compelling combination.”
EML is an unlisted public company incorporated under the laws of New South Wales, Australia. It is a U.S.-based resource company, with its material asset being the 100-per-cent-owned Corcoran Canyon silver project in Nevada. EML also holds a high-grade manganese project in Minnesota, United States.
About ThreeD Capital Inc.
ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company’s ecosystem.
For further information: Gerry Feldman, CPA, CA Chief Financial Officer and Corporate Secretary [email protected] Phone: 416-941-8900 ext 106
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
Forward-Looking Statements
This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as “forward-looking statements”) within the meaning of Canadian securities laws including, without limitation, statements with respect to the future investments by the Company. All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward-looking statements will not occur. Although the Company believes that the expectations reflected in the forward looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company’s actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.
